$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 9, 2025)
$4.58B
Market Cap
37.35
P/E Ratio
0.98
EPS
$38.00
52 Week High
$7.62
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Indivior PLC is a leading biopharmaceutical company headquartered in North Chesterfield, Virginia, focused on developing innovative treatments for opioid dependence and related disorders. Known for its pioneering work with buprenorphine-based therapies, Indivior aims to improve patient outcomes and tackle the complexities associated with opioid use disorder. The company demonstrates a strong commitment to public health through substantial investments in research and development, reinforcing its position as a transformative leader in addiction treatment. With a comprehensive product portfolio and a dedicated patient-centric approach, Indivior is well-prepared to address the evolving challenges within the healthcare landscape.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG